key: cord-0064625-hmqtphqi
authors: Cai, Lingxin; Zeng, Hanhai; Tan, Xiaoxiao; Wu, Xinyan; Qian, Cong; Chen, Gao
title: The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage
date: 2021-06-03
journal: Front Neurol
DOI: 10.3389/fneur.2021.671098
sha: 407b8679a01f88fb00ae344e68ab74cff4fb47d2
doc_id: 64625
cord_uid: hmqtphqi

Aneurysmal subarachnoid hemorrhage (aSAH) is an important type of stroke with the highest rates of mortality and disability. Recent evidence indicates that neuroinflammation plays a critical role in both early brain injury and delayed neural deterioration after aSAH, contributing to unfavorable outcomes. The neutrophil-to-lymphocyte ratio (NLR) is a peripheral biomarker that conveys information about the inflammatory burden in terms of both innate and adaptive immunity. This review summarizes relevant studies that associate the NLR with aSAH to evaluate whether the NLR can predict outcomes and serve as an effective biomarker for clinical management. We found that increased NLR is valuable in predicting the clinical outcome of aSAH patients and is related to the risk of complications such as delayed cerebral ischemia (DCI) or rebleeding. Combined with other indicators, the NLR provides improved accuracy for predicting prognosis to stratify patients into different risk categories. The underlying pathophysiology is highlighted to identify new potential targets for neuroprotection and to develop novel therapeutic strategies.

Aneurysmal subarachnoid hemorrhage (aSAH) is the leading cause of death in stroke patients, with a mortality rate of ∼40-50% (1, 2) . More than 30% of survivors may develop severe disability and delayed neurological dysfunction due to complications such as delayed cerebral ischemia (DCI) and rebleeding (3) . The progression of aSAH is individualized and rapid, so accurate risk stratification and prognosis prediction is challenging (4) . A growing body of research has found that neuroinflammation and immune disorders after aSAH may play an important role in both early brain injury (EBI) and delayed neurological injury (5) . Neutrophils and lymphocytes are vital inflammatory cells and participate in many pathogenic processes (6) , such as endothelial injury, blood-brain barrier (BBB) destruction, microcirculation disturbance, and vasospasm (7) . The dynamics of inflammatory cells and cytokines in the periphery can also contribute to systemic inflammatory response syndrome (SIRS) (8) and immunosuppression (9) , which can perhaps increase the risk of infection (10) .

The neutrophils-to-lymphocyte ratio (NLR) is a parameter that reflects inflammation and is regarded as a predictor of cardiovascular disease, pancreatitis, tumors, and other diseases (11) . At present, several studies have shown that an increase in the NLR can predict adverse outcomes in patients with intracerebral hemorrhage (ICH) (12, 13) . Because aSAH has a disease model similar to that of intracranial hemorrhage (14) , the NLR may have the potential to assist in the prediction of the prognosis of aSAH.

The purpose of this review is to summarize existing evidence on the relationship between the NLR and aSAH and evaluate whether the NLR can be used to predict outcomes and as an effective biomarker for clinical management. We will also provide important insights into the underlying pathophysiological mechanisms and discuss the limitations of the current studies to make recommendations for future research.

After aneurysm rupture, the blood enters the subarachnoid space and spreads to the brain through the cerebrospinal fluid (CSF). Erythrocytes degrade and release many bioactive and potentially toxic molecules (15) , destroying blood vessels and initiating an inflammatory cascade reaction (16) . Inflammation regulated by complex pathways plays a pivotal role in both neurological impairment and destruction (17) . Microglia are resident immune cells in the central nervous system (CNS) and react rapidly to inflammation-associated neurological injuries (18) . When activated by toll-like receptor 4 (TLR4), microglia switch to a proinflammatory phenotype (M1) and secrete a large number of proinflammatory chemokines and cytokines, such as interleukin-6 (IL-6), interleukin-1β (IL-1β) (19) , tumor necrosis factor-alpha (TNF-α), and nitric oxide (NO) (20) . These inflammatory factors can increase the expression of specific cell adhesion molecules (CAMs) on the luminal surface of endothelial cells (ECs), recruit macrophages and neutrophils to bind ECs, and enter the CNS (21). After migrating to the subarachnoid space, neutrophils are essential in clearing extravascular hemoglobin through the Hp-Hgb complex, and this process is a response to hemorrhage that promotes neural stability and recovery (22, 23).

The acute neuroinflammatory response influences delayed events such as rebleeding and DCI after aSAH (24, 25). The recruitment of neutrophils and lymphocytes damages the blood vessel wall, resulting in the thinning of the aneurysm wall and coagulation dysfunction (26, 27). Recent studies have highlighted the role of the neuroinflammation of the microvasculature in DCI (28). Inflammation disrupts the balance between endogenous vasodilators and vasoconstrictors, especially the production of NO and endothelin-1 (29). This imbalance can increase lipid peroxidation of the cell membrane and direct oxidative stress in smooth muscle cells (30), causing microperfusion disorders and cerebral ischemic infarction (31). The interaction of neutrophils with platelets and vascular endothelium has also been demonstrated (32). Some clinical evidence shows that the increase of neutrophils in CSF indicates vascular injury and may be an independent predictor of vasospasm, indicating the risk of DCI (33, 34). Further studies have found additional pathogenic mechanisms, such as EBI and apoptosis, destruction of the BBB (35), micro thromboembolism (36), and cortical diffuse depolarization (37), which are more or less linked to inflammation.

Neutrophils migrate to the damaged brain tissue at the earliest stage and reach a peak in the early stage (24-48 h) (38). Neutrophils interact with activated ECs and play an important role in aggravating the inflammatory response, leading to the destruction of the BBB, brain edema, hypoperfusion, and nerve cell injury (39). Targeting neutrophil function could mitigate cerebral hypoperfusion (40, 41) , and inhibition of neutrophil-endothelial interactions markedly decreased neuronal cell death and reduced secondary brain injury (42) . The mechanism pathway involves inflammatory factors released by neutrophils, such as reactive oxygen species, cathepsin (43) , matrix metalloproteinase-9 (MMP-9), and myeloperoxidase (MPO) (44) . Neutrophils show significant procoagulant effects and aggravate the disturbance of the microcirculation (45) .

The activation of inflammation and an increase in neutrophils also occur in the peripheral immune system (46, 47) . The interruption of the BBB or the CSF drainage system may serve as a communication channel for inflammatory factors (48, 49). The peripheral activation of innate immune cells after aSAH is regulated by the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis (50, 51) . These changes in the peripheral inflammatory status and the resulting symptoms may manifest as SIRS (52) . The occurrence of SIRS with common characteristics, like body temperature, heart rate, blood pressure, leukocytosis, and platelet activation, usually leads to continuous tissue hypoperfusion and damage to microcirculatory blood flow (53, 54) . In return, systemic hyperinflammation provoked by maladaptive innate immunity may activate innate immune signaling pathways in the CNS, increasing BBB destruction (55).

Adaptive immunity is active in both the CSF and periphery after aSAH (56) . Lymphocytes are found in the CNS after aSAH and are mainly involved in the protective mechanism against brain injury (57) . Tregs play a key role in the elimination of inflammation and are the main brain-protective immunomodulator (58, 59) . Tregs can reduce the inflammatory response by blocking the activation of the TLR4/nuclear factorkappa B (NF-κB) signaling pathway, inducing the transformation of microglia toward a more favorable M2-like phenotype inhibiting the effect of neutrophil-derived MMP-9 to protect the integrity of the BBB and EC function (60, 61) . The potent homeostatic function of Tregs in the peripheral immune system involves the inhibition of early immune overactivation that may result in an exhausted immune phenotype (62) . In contrast, Th17 cells promote the inflammatory response (63) and are an important source of pro-inflammatory cytokines to aggravate brain injury (64) .

A decrease in the total number of lymphocytes, especially Tregs, is found in aSAH patients (65) . The profound loss of lymphocytes and the reduction of their activation are defined as pathophysiological immunosuppression, which is a longlasting state that can last for several weeks and has a complex mechanism. The autonomic nervous system (ANS) and the SNS affect immune responses in the periphery and play a major role in immunosuppression (66) . The stress response induced by injury activates the HPA axis and also leads to deficiency in the early activation of lymphocytes (67) . Neutrophils release arginase 1 (ARG1), resulting in T-lymphocyte suppression in peripheral blood (68) . Immunosuppression is also associated with changes in related cytokines released by lymphocytes, such as decreases in interferon-gamma (INF-γ) and interleukin-10 (IL-10) (69, 70) . Lymphocytes are crucial for host defense against pathogens, and apparently, concomitant immunosuppression can increase vulnerability to systemic infection (71) .

We reviewed relevant studies that associate NLR with aSAH to evaluate whether the NLR could serve as a biomarker to predict outcomes and be used as an effective biomarker for clinical management. A total of 11 studies assessed short-or long-term clinical outcomes according to the Modified Rankin Scale (mRS), early neurological deterioration, mortality, the occurrence of DCI, and other parameters. The synopses of the studies include the primary endpoint, inclusion criteria, and exclusion criteria, which are summarized in Table 1 . The main characteristics of the patients enrolled in the studies are summarized in Table 2 . The main conclusions are summarized in Table 3 .

The relationship between the NLR and unfavorable clinical outcomes was investigated in a retrospective cohort study. Giede-Jeppe et al. described 319 patients in a tertiary inpatient center in Germany and recorded the mRS score at 3 and 12 months. It was found that the NLR value of patients with an unfavorable prognosis was significantly increased. After adjustment, the NLR remained an important factor in predicting unfavorable outcomes in patients. Through receiver operating characteristic (ROC) analysis, an NLR ≥7.05 was determined as the best cutoff value to predict unfavorable outcomes, which indicated an mRS score of 3-6 after 3 months (75). Wang et al. also found that there was a positive correlation between the NLR and the Hunt-Hess grade and that the NLR could predict the adverse outcomes of patients with an mRS score of 3-5 after 3 months (73) . In a study that included 247 patients, the NLR was proven to be an independent predictor of adverse outcomes after 3 months, with a sensitivity of 74.5% and a specificity of 69.3% (81) .

The NLR was also an independent marker of mortality in patients with aSAH. Huang et al. found that the increase in the NLR in intensive care unit (ICU) patients was significantly associated with hospital mortality and 1-year mortality (80). Jamali et al. found that the NLR value of patients who died in the hospital was significantly higher than that of surviving patients, and the in-hospital mortality rate of patients with an NLR ≥12.5 increased significantly. In this study, the effects of the absolute neutrophil count and absolute lymphocyte count on mortality were compared separately, and the results showed that there was no difference (72). Yilmaz et al. also found that the NLR was associated with the Fisher score and mortality and was a simple indicator of aSAH patient severity and short-term mortality (79) .

The main complications of aSAH are DCI and rebleeding, which are common clinically and cause severe disability and delayed neurological dysfunction. A single-center, prospective, observational cohort study of 1,067 patients at Columbia University Medical Center demonstrated that the NLR on admission could predict the occurrence of DCI. They found that in the multivariate model, an increased NLR was associated with a poor Hess grade on admission, Caucasian race, the location of the anterior aneurysm, loss of consciousness at onset, and an increased bleeding volume (Fisher ≥ 3). After controlling for known predictors such as age, poor clinical grade on admission, bleeding volume, and mean arterial pressure on admission, the admission NLR could predict the occurrence of DCI, and an NLR ≥5.9 on admission predicted a 2-fold increase in the risk of DCI (74).

Wu et al. also found that the NLR may be a practical index to predict the occurrence of DCI in aSAH patients. They studied 122 patients, and 43 of them developed DCI during hospitalization and had an increased white blood cell count, neutrophil count, and NLR and a lower lymphocyte count. The NLR value was the most predictive variable among the four variables, and the best predictive value was 11.47. The sensitivity and specificity were 58.1 and 82.3%, respectively (77) . The findings of Tao et al. also supported these results, as they found that an increased NLR was an independent factor that predicted the occurrence of DCI, with a sensitivity of 87.3% and a specificity of 48.4% (81). Ray et al. carried out further studies on the dynamics of the NLR and found that NLR trends showed a significant initial decline followed by a gradual rise among those without DCI, whereas the NLR was persistently low in those patients that developed DCI in an early immune-depressed state after aSAH (76) .

The relationship between the NLR and rebleeding was proven as well. In a study that included 716 patients with aSAH, rebleeding occurred in 4.19% of patients. Univariate analysis showed that the NLR in patients with rebleeding was significantly higher than that in patients without rebleeding. In the multivariate analysis, the NLR and Fisher grade were risk factors for rebleeding. An increased NLR predicted the occurrence of rebleeding and poor prognosis after aSAH. In addition, a model combining the NLR and the Fisher grade was more valuable for predicting rebleeding than a single NLR or Fisher rating model, with a specificity of 100% (73) .

The mortality rate of aSAH is quite high, and survivors are typically left with prolonged functional impairments, but accurate estimation of the prognosis of aSAH patients has been challenging (83) . At present, the most important prognostic determinants for the aSAH outcome are the neurological grade on initial examination, radiographic results, and age (84, 85) . However, subjective differences are inevitable in using the grading scales (86) , and the sensitivity of the radiograph depends on the time interval between symptom occurrence and image acquisition (87) . Researchers are hardpressed to find new, feasible, and accurate evaluation and prediction methods. Severe subarachnoid hemorrhage is associated with the strong early inflammatory response (88) , and the most direct and easily observed result is the change in peripheral inflammatory biomarkers, such as the neutrophil and lymphocyte counts (89, 90) . In general, an increase in neutrophils in peripheral blood is a manifestation of inflammation in the CNS and may be related to the development of extracerebral organ immune dysfunction. And SIRS associated with neutrophils is also related to poor clinical grade and independently predicts poor outcomes (91) . A decrease in lymphocytes suggests the loss of neuroprotection and the impairment of native immunity with immunosuppression in the periphery (92) . Therefore, NLR is a peripheral biomarker that conveys information about the inflammatory burden in terms of both innate and adaptive immunity and may fill the current lack of prognosis prediction.

It is understood that NLR is easy to utilize clinically without additional costs. As a ratio, the NLR remains more reliable and stable than a single blood parameter and is not affected by factors such as dehydration, overhydration, and blood sample treatment (93, 94) . In addition, the NLR is more specific, multidimensional, and sensitive when slight changes in the inflammatory status of patients are difficult to detect (95) . In conjunction with imaging results and the neurological grade, the NLR is of great value for the risk stratification process and the guidance of early prevention (96) .

The complications of aSAH include rebleeding, DCI, hydrocephalus, increased intracranial pressure, and seizures (97) . Previous studies have highlighted rebleeding and DCI, which contribute to high rates of disability and neurological dysfunction in survivors and are independent predictors of unfavorable outcomes (98) . Rebleeding events are defined as a new hemorrhage apparent on repeat computed tomography (CT) with or without new symptoms and are viewed as the cerebrovascular equivalent of a second hit (99, 100) . One of the causes of adverse clinical outcomes is the delayed diagnosis and treatment of rebleeding (101, 102) . There is no sensitive Wang et al. (73) Higher NLR predicts the occurrence of rebleeding and poor outcome at 3 months, and NLR combined with Fisher grade significantly improves the prediction of rebleeding following aSAH. The AUC values of the NLR and combined NLR-Fisher grade model were 0.702 and 0.744 (sensitivity was 39.94%, and specificity was 100%), respectively, for predicting rebleeding. After PSM, the optimal cutoff value for NLR as a predictor for rebleeding following aSAH was determined as 5.4 (sensitivity was 83.33%, and the specificity was 63.33%).

Al-Mufti et al. (74) Admission NLR predicted development of DCI, a sensitivity of 63% and specificity of 53% for predicting DCI.

Giede-Jeppe et al. (75) NLR represents an independent parameter associated with unfavorable functional outcome for aSAH; an NLR of 7.05 was identified as the best cutoff value to discriminate between favorable and unfavorable outcomes.

Ray et al. (76) NLR trends showed a significant initial decline among those without DCI, a gradual rise in those developing DCI, and an early immune-depressed state after aSAH. and facile prediction method for prioritizing early treatment, such as early or ultra-early aneurysm repair and the use of antifibrinolytic drugs (103, 104) . The NLR has been shown to predict the occurrence of rebleeding, which may be explained by the mechanism that neutrophil recruitment changes the stability of the ruptured aneurysm wall (73, 105) . The present study on the NLR and rebleeding is limited but indicates potential predictors and new strategies for addressing neuroinflammation in rebleeding. DCI generally occurs within 2 weeks after subarachnoid hemorrhage and is caused by cerebral perfusion defects (106) , resulting in the deterioration of neurological function and a dramatically decreased quality of life in most survivors (107) . The challenge is how to predict the occurrence of DCI and then formulate effective preventive strategies to reverse the development of DCI in advance (108) . At present, four clinical studies have proven that the NLR is an independent prognostic factor for the occurrence of DCI with strong sensitivity and specificity (74, 76, 77, 81) . This implies that the NLR is promising as a new predictor for DCI to help classify patients and direct preventive treatment to those who are most likely to benefit.

Increasing evidence shows that immune system disorders after aSAH and the risk of infection are increased (109) . Immunosuppression induced by a significant decrease in peripheral lymphocytes is perhaps the vital reason for the increased risk of infection, especially in critically ill patients (110) . Patients with SIRS also tend to become infected (111) .

Within 24 h after aSAH, an increase in the NLR may indicate the occurrence of intense early inflammation, which could develop into a strong late inflammatory response (112) . Patients with a high NLR are more likely to develop pneumonia during hospitalization (113) , and an NLR ≥5.9 is associated with pulmonary edema and high fever (74) . The average number of neutrophils in patients with pneumonia is significantly increased (72) . In particular, patients with DCI have a higher NLR and are more likely to be infected at a later stage (76) . The NLR is an accessible indicator to evaluate immunity status and infection risk and can help adjust treatment strategies for preventing postoperative infectious complications (114) .

Further study could focus on the comparison of the role of neutrophils and lymphocytes in different neurological diseases. Current studies have shown that NLR is associated with a variety of diseases, such as ischemic stroke, other ICH (115) , and traumatic brain injury. A number of studies have shown that NLR was predictive of short-term functional outcome in acute ischemic stroke (AIS) (116) . A high NLR was also found to be an independent predictor for the complications following AIS including cerebral edema (117) , hemorrhagic transformation after ischemia (118) , and the development of ICH after endovascular treatment (119) .

Neuroinflammation is prevalent in these conditions and plays with similar mechanisms. In the early stage of both SAH and AIS, the activation of microglia by neutrophil is vital for following cascade of inflammation, with similar inflammatory mediators and pathways (120) . Moreover, Tregs also play a major role in immunomodulatory function and neuroprotection after AIS (121). Valuable findings and breakthroughs may occur through comparing the similarities and differences of pathophysiological mechanisms about neuroinflammation among these medical conditions.

Furthermore, systematic and quantitative analyses of relevant clinical studies are needed to explore different levels and trends of NLR in multiple diseases, which could develop potential and guiding clinical applications. Ogden et al. studied patients in the neonatal intensive care unit (NICU) and found that the NLR was higher in aSAH than in traumatic subarachnoid hemorrhage (78) . Eryigit et al. also found that the NLR can be used in distinguishing aSAH and migraine, with different levels and changes of NLR (122) . The different cutoff values may be useful in specific classifications for etiologies.

NLR is proven to be a useful and potential tool in distinguishing between aSAH and SAH of other etiologies (82) . The potential mechanism may be that neuroinflammation plays a significant role during the formation and rupture of cerebral aneurysms (123) . Neutrophil infiltration and pro-inflammatory cytokine overexpression cause thinning of the aneurysm wall and coagulation dysfunction (124, 125) . However, the hypothesis that the NLR may be used as an early warning index before aneurysm rupture requires more exploration regarding the pathology of aneurysm progression and neuroinflammation.

It is encouraging that combining the NLR with other indicators can enhance the predictive value. The combined NLR-Fisher score model significantly improves the ability to predict the outcome of aSAH with higher sensitivity and specificity (74) . Combining the NLR with the platelet-to-lymphocyte ratio (PLR) is more sensitive for aSAH than either indicator alone (81, 126) . The prognosis of neurological diseases is affected by a number of factors, and combining NLR with other potential indicators may be a potential way to improve the prediction accuracy and clinical value of NLR. Lattanzi et al. found that the accuracy of outcome prediction in acute ICH would increase when NLR combined with the modified ICH score (127) . NLR combined with patient characteristics like gender, a history of hypertension, diabetes mellitus, and smoking could present high diagnostic accuracy in ischemic stroke (128, 129) . NLR combined with PLR was also found to be more meaningful in the early clinical detection of post-stroke depression than either alone (130) .

Further studies may focus on the application of the NLR as a new potential target for developing novel therapeutic strategies (131) . Neutrophils and lymphocytes show the potential to have substantial beneficial effects. Preclinical studies have shown that selective limitation of neutrophil activity can reduce neuroinflammation and neuronal apoptosis, eventually protecting the microcirculation and improving prognosis (132) . Therapeutic strategies for T lymphocytes, such as the use of cyclosporine, have also been shown to be effective in some studies (133, 134) . Many studies have evaluated drugs aimed at inhibiting inflammation, but the results have been mixed and not as obvious as originally hoped (135) . It is not advisable to inhibit overall inflammation, and immunomodulatory methods should aim to block harmful effects selectively rather than functioning as an extensive, non-selective anti-inflammatory therapy (136, 137) . Future treatment strategies should focus on subtle regulation of the immune response, which requires the precise assessment of inflammation, and the NLR may be a promising index for this.

There are many areas of uncertainty regarding the evaluation of the NLR as a prognostic marker in aSAH and new therapeutic targets. To some extent, the conclusions of clinical studies may overestimate the causality and clinical correlation between the NLR and aSAH, for the existence of confounding factors is inevitable (138) . In addition, the admission criteria of studies are not harmonized or standardized, and some are not strict enough. Moreover, the sampling time of all studies is at the time of admission, which ignores the fact that the NLR is a dynamic index (23, 139). The current research can only prove the predictive role of the NLR on admission; a further prospective study is needed to provide time trend data to explore the overall dynamic changes.

Undoubtedly, further multicenter, large-sample, prospective, standardized evaluation studies are needed to confirm the detailed mechanisms and causal link between the NLR and aSAH. Additionally, all candidate biomarkers and molecules in the upstream pathways should be further explored for the detection of target antigens that link central and peripheral inflammation and to help identify other new targets (140) .

Present studies have demonstrated that NLR may be useful for predicting clinical outcome and the risk of complications in patients with aSAH. And the underlying pathophysiology mechanism of neuroinflammation is highlighted to further support this conclusion. However, NLR may present an insufficient specificity when it plays a predictive role in a variety of medical conditions. Combining NLR with other relevant prognosis factors may be a potential way to improve the predictive ability and clinical value of NLR. Despite the complexities of neuroinflammation and deficiency of present studies, modulating levels of neutrophils and lymphocytes and relevant signal transduction pathways could be a clinical therapeutic intervention in aSAH.

LC and HZ wrote and revised the manuscript. XW and XT helped in finding references. All authors contributed to the article and approved the submitted version. 

Subarachnoid haemorrhage: diagnosis, causes and management

Subarachnoid haemorrhage

Spontaneous subarachnoid haemorrhage

Misdiagnosis worsens prognosis in subarachnoid hemorrhage with good hunt and hess score

Inflammatory pathways following subarachnoid hemorrhage

Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage

Decreased progranulin levels in patients and rats with subarachnoid hemorrhage: a potential role in inhibiting inflammation by suppressing neutrophil recruitment

Early brain injury associated with systemic inflammation after subarachnoid hemorrhage

Immunodepression after aneurysmal subarachnoid hemorrhage

High neutrophilto-lymphocyte ratio predicts stroke-associated pneumonia

Association of neutrophil-tolymphocyte ratio with mortality and cardiovascular disease in the jackson heart study and modification by the duffy antigen variant

Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets

Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy

The association of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with 3-month clinical outcome after mechanical thrombectomy following stroke

Haptoglobin therapeutics and compartmentalization of cell-free hemoglobin toxicity

Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage

Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review

Modulators of microglial activation and polarization after intracerebral haemorrhage

The dynamics of microglial polarization reveal the resident neuroinflammatory responses after subarachnoid hemorrhage

Interaction of microglia and astrocytes in the neurovascular unit

Neutrophils mediate early cerebral cortical hypoperfusion in a murine model of subarachnoid haemorrhage

In vivo molecular MRI of ICAM-1 expression on endothelium and leukocytes from subacute to chronic stages after experimental stroke

Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH)

Pristimerin inhibits MMP-9 expression and cell migration through attenuating NOX/ROS-dependent NF-κB activation in rat brain astrocytes challenged with LPS

Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice

Leukocyte count and intracerebral hemorrhage expansion

Innate immunity activation in the early brain injury period following subarachnoid hemorrhage

Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells

Immune response mediates the cardiac damage after subarachnoid hemorrhage

Neuronal regulation of immunity: why, how and where?

Distribution of nerve fibers and nerve-immune cell association in mouse spleen revealed by immunofluorescent staining

Time from onset of SIRS to antibiotic administration and outcomes after subarachnoid hemorrhage

Stroke severity, and not cerebral infarct location, increases the risk of infection

The local and peripheral immune responses to stroke: implications for therapeutic development

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports

The movers and shapers in immune privilege of the CNS

High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease

Protective and regenerative roles of T cells in central nervous system disorders

Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation

Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury

Adoptive regulatory Tcell therapy protects against cerebral ischemia

Regulatory T cells in post-stroke immune homeostasis

Dysregulation of proinflammatory versus anti-inflammatory human T17 cell functionalities in the autoinflammatory Schnitzler syndrome

Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage

Protective and pathological immunity during central nervous system infections

Activation of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the immunosuppression of mice infected with Angiostrongylus cantonensis

Functional role of regulatory lymphocytes in stroke: facts and controversies

Gene expression profiling in stroke: relevance of blood-brain interaction

Elevated systemic IL-10 levels indicate immunodepression leading to nosocomial infections after aneurysmal Subarachnoid hemorrhage (SAH) in patients

Interleukin 10 (IL-10)-mediated immunosuppression: MARCH-I induction regulates antigen presentation by macrophages but not dendritic cells

T lymphocytes cash their value in clinical medicine

Elevated neutrophil-lymphocyte ratio is predictive of poor outcomes following aneurysmal subarachnoid hemorrhage

Admission neutrophil-lymphocyte ratio predicts rebleeding following aneurismal subarachnoid hemorrhage

Admission neutrophil-lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage

Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage

Systemic response of coated-platelet and peripheral blood inflammatory cell indices after aneurysmal subarachnoid hemorrhage and long-term clinical outcome

The association of neutrophil-to-lymphocyte ratio and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: possible involvement of cerebral blood perfusion

Analysis of biochemical laboratory values to determine etiology and prognosis in patients with subarachnoid hemorrhage: a clinical study

Admission neutrophil to lymphocyte and platelet to lymphocyte ratio as a predictor of mortality in patients with subarachnoid hemorrhage

Red blood cell distribution width and neutrophil to lymphocyte ratio are associated with outcomes of adult subarachnoid haemorrhage patients admitted to intensive care unit

Clinical value of neutrophil to lymphocyte and platelet to lymphocyte ratio after aneurysmal subarachnoid hemorrhage

Comparison of the diagnostic values of neutrophil, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio in distinguishing spontaneous subarachnoid hemorrhage from nontraumatic acute headache

Short and long-term outcome of aneurysmal subarachnoid hemorrhage patients

External validation of the subarachnoid hemorrhage international trialists (SAHIT) predictive model using the barrow ruptured aneurysm trial (BRAT) Cohort

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage

Prediction of cerebral infarction and patient outcome in aneurysmal subarachnoid hemorrhage: comparison of new and established radiographic, clinical and combined scores

Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study

Early inflammatory response in the brain and anesthesia recovery time evaluation after experimental subarachnoid hemorrhage

Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage

Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage

Systemic inflammatory response syndrome as predictor of poor outcome in nontraumatic subarachnoid hemorrhage patients

Cytotoxic function of CD8+ T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke-induced immunosuppression

The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam study

Higher neutrophil counts and neutrophil-to-lymphocyte ratio predict prognostic outcomes in patients after non-atrial fibrillation-caused ischemic stroke

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophagogastric cancer: exploratory analysis of the REAL-2 trial

Neutrophil-lymphocyte ratio and perihematomal edema growth in intracerebral hemorrhage

Predictors of in-hospital death after aneurysmal subarachnoid hemorrhage: analysis of a nationwide database

Validation and optimization of barrow neurological institute score in prediction of adverse events and functional outcome after subarachnoid hemorrhage-creation of the HATCH (hemorrhage, age, treatment, clinical state, hydrocephalus) score

Impact of perioperative aneurysm rebleeding after subarachnoid hemorrhage

Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia: a propensity-score matched cohort study

Aneurysm rebleeding after poor-grade aneurysmal subarachnoid hemorrhage: predictors and impact on clinical outcomes

Twenty-four-hour emergency intervention versus early intervention in aneurysmal subarachnoid hemorrhage

Desmopressin administration and rebleeding in subarachnoid hemorrhage: analysis of an observational prospective database

Time intervals from subarachnoid hemorrhage to rebleed

Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study

Management of 350 aneurysmal subarachnoid hemorrhages in 22 Italian neurosurgical centers

Preconditioning effect on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

The VASOGRADE: a simple grading scale for prediction of delayed cerebral ischemia after subarachnoid hemorrhage

Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH

Systemic inflammation in hemorrhagic strokes -a novel neurological sign and therapeutic target?

Elevated systemic IL-6 levels in patients with aneurysmal subarachnoid hemorrhage is an unspecific marker for post-SAH complications

The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study

Immune activation in the peripheral blood of patients with acute ischemic stroke

Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens

Clinical value of neutrophil-to-lymphocyte ratio in primary intraventricular hemorrhage

Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke

Neutrophil-to-lymphocyte ratio predicts cerebral edema and clinical worsening early after reperfusion therapy in stroke

Neutrophil-to-lymphocyte ratio and symptomatic hemorrhagic transformation in ischemic stroke patients undergoing revascularization

Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke

Mucosal-associated invariant t cells are involved in acute ischemic stroke by regulating neuroinflammation

The diagnostic value of the neutrophil-lymphocyte ratio in distinguishing between subarachnoid hemorrhage and migraine

The vascular protective role of oestradiol: a focus on postmenopausal oestradiol deficiency and aneurysmal subarachnoid haemorrhage

Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study

Predictive value of mean platelet volume for aneurysm recurrence in patients with aneurysmal subarachnoid hemorrhage after endovascular treatment

Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage

Application of neutrophil to lymphocyte ratio to identify CT-negative cerebral infarction with nonfocal symptoms

Neutrophilto-lymphocyte ratio, hyperglycemia, and outcomes in ischemic stroke patients treated with intravenous thrombolysis

Elevated neutrophil-tolymphocyte and platelet-to-lymphocyte ratios predict post-stroke depression with acute ischemic stroke

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury

Immune cells subpopulations in cerebrospinal fluid and peripheral blood of patients with

Investigation of the mechanisms of neuroprotection mediated by Ro5-4864 in brain injury

CNS delivery and anti-inflammatory effects of intranasally administered cyclosporine-A in cationic nanoformulations

Targeting vascular inflammation in ischemic stroke: recent developments on novel immunomodulatory approaches

Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study

Multifaceted interactions between adaptive immunity and the central nervous system

Impact of treatment delay on outcome in the international subarachnoid aneurysm trial

Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke

Blood/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns